| Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: an update of the Memorial Sloan-Kettering Cancer Center experience J Setton, N Caria, J Romanyshyn, L Koutcher, SL Wolden, MJ Zelefsky, ... International Journal of Radiation Oncology* Biology* Physics 82 (1), 291-298, 2012 | 203 | 2012 |
| The therapeutic significance of mutational signatures from DNA repair deficiency in cancer J Ma, J Setton, NY Lee, N Riaz, SN Powell Nature communications 9 (1), 3292, 2018 | 192 | 2018 |
| 18F-FDG PET/CT metabolic tumor volume and total lesion glycolysis predict outcome in oropharyngeal squamous cell carcinoma R Lim, A Eaton, NY Lee, J Setton, N Ohri, S Rao, R Wong, M Fury, ... Journal of Nuclear Medicine 53 (10), 1506-1513, 2012 | 192 | 2012 |
| Distinct classes of complex structural variation uncovered across thousands of cancer genome graphs K Hadi, X Yao, JM Behr, A Deshpande, C Xanthopoulakis, H Tian, ... Cell 183 (1), 197-210. e32, 2020 | 167 | 2020 |
| Mutations in BRCA1 and BRCA2 differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapy RM Samstein, C Krishna, X Ma, X Pei, KW Lee, V Makarov, F Kuo, ... Nature cancer 1 (12), 1188-1203, 2020 | 137 | 2020 |
| A multi‐institution pooled analysis of gastrostomy tube dependence in patients with oropharyngeal cancer treated with definitive intensity‐modulated radiotherapy J Setton, NY Lee, N Riaz, SH Huang, J Waldron, B O'Sullivan, Z Zhang, ... Cancer 121 (2), 294-301, 2015 | 131 | 2015 |
| Synthetic lethality in cancer therapeutics: the next generation J Setton, M Zinda, N Riaz, D Durocher, M Zimmermann, M Koehler, ... Cancer discovery 11 (7), 1626-1635, 2021 | 103 | 2021 |
| Intensity-modulated radiation therapy in oropharyngeal carcinoma: effect of tumor volume on clinical outcomes BH Lok, J Setton, N Caria, J Romanyshyn, SL Wolden, MJ Zelefsky, ... International Journal of Radiation Oncology* Biology* Physics 82 (5), 1851-1857, 2012 | 80 | 2012 |
| Characteristics and outcomes of sentinel node–positive breast cancer patients after total mastectomy without axillary-specific treatment S Milgrom, H Cody, L Tan, M Morrow, C Pesce, J Setton, K Rogers, ... Annals of surgical oncology 19, 3762-3770, 2012 | 78 | 2012 |
| Efficacy of concurrent cetuximab vs. 5-fluorouracil/carboplatin or high-dose cisplatin with intensity-modulated radiation therapy (IMRT) for locally-advanced head and neck … LQ Shapiro, EJ Sherman, N Riaz, J Setton, L Koutcher, Z Zhang, W Shi, ... Oral oncology 50 (10), 947-955, 2014 | 62 | 2014 |
| Definitive treatment of metastatic nasopharyngeal carcinoma: Report of 5 cases with review of literature J Setton, S Wolden, N Caria, N Lee Head & neck 34 (5), 753-757, 2012 | 60 | 2012 |
| Predictive modeling of outcomes following definitive chemoradiotherapy for oropharyngeal cancer based on FDG-PET image characteristics MR Folkert, J Setton, AP Apte, M Grkovski, RJ Young, H Schöder, ... Physics in Medicine & Biology 62 (13), 5327, 2017 | 58 | 2017 |
| Percutaneous endoscopic gastrostomy in oropharyngeal cancer patients treated with intensity‐modulated radiotherapy with concurrent chemotherapy PB Romesser, JC Romanyshyn, KD Schupak, J Setton, N Riaz, ... Cancer 118 (24), 6072-6078, 2012 | 56 | 2012 |
| Pathogenic ATM Mutations in Cancer and a Genetic Basis for Radiotherapeutic Efficacy KL Pitter, DL Casey, YC Lu, M Hannum, Z Zhang, X Song, I Pecorari, ... JNCI: Journal of the National Cancer Institute 113 (3), 266-273, 2021 | 53 | 2021 |
| Long-term patterns of relapse and survival following definitive intensity-modulated radiotherapy for non-endemic nasopharyngeal carcinoma J Setton, J Han, D Kannarunimit, YR Wuu, SA Rosenberg, C DeSelm, ... Oral oncology 53, 67-73, 2016 | 52 | 2016 |
| Estimate of the impact of FDG-avidity on the dose required for head and neck radiotherapy local control J Jeong, JS Setton, NY Lee, JH Oh, JO Deasy Radiotherapy and Oncology 111 (3), 340-347, 2014 | 44 | 2014 |
| Long‐term regional control in the observed neck following definitive chemoradiation for node‐positive oropharyngeal squamous cell cancer A Goenka, LGT Morris, SS Rao, SL Wolden, RJ Wong, DH Kraus, N Ohri, ... International journal of cancer 133 (5), 1214-1221, 2013 | 43 | 2013 |
| Dose-volume factors correlating with trismus following chemoradiation for head and neck cancer SD Rao, ZH Saleh, J Setton, M Tam, SM McBride, N Riaz, JO Deasy, ... Acta Oncologica 55 (1), 99-104, 2016 | 42 | 2016 |
| The relative prognostic utility of standardized uptake value, gross tumor volume, and metabolic tumor volume in oropharyngeal cancer patients treated with platinum based … PB Romesser, R Lim, DE Spratt, J Setton, N Riaz, B Lok, S Rao, ... Oral oncology 50 (9), 802-808, 2014 | 42 | 2014 |
| Radiation field design and regional control in sentinel lymph node‐positive breast cancer patients with omission of axillary dissection J Setton, H Cody, L Tan, M Morrow, C Hudis, J Catalano, B McCormick, ... Cancer 118 (8), 1994-2003, 2012 | 37 | 2012 |
